BioSpace News Archive

Business

NHCAA Elects New Board Chair Sara “Sally” Walker

Sara “Sally” Walker, Vice President, Enterprise Risk Management at Blue Cross Blue Shield of Massachusetts elected as 2020 Chair of the NHCAA Board of Directors

October 15, 2019
·
3 min read
Business

Valens Reports Record Revenue, Adjusted EBITDA and Profitability for the Third Quarter of Fiscal 2019

Valens GroWorks Corp. (TSXV: VGW) (OTC: VGWCF) (the “Company” or “Valens”), a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analytical lab is pleased to report its financial results for the third quarter of fiscal 2019.

October 15, 2019
·
9 min read
FDA

Akebia Files Lawsuit Against CMS for 2018 Action Rescinding Medicare Part D Coverage of FDA-Approved Auryxia® for its Iron Deficiency Anemia Indication

CMS continues to deny Medicare beneficiaries with chronic kidney disease full access to this innovative therapy

October 15, 2019
·
6 min read
Drug Development

Denovo Biopharma Receives FDA’s Permission to Proceed with a Biomarker-Guided Phase 2b Clinical Trial with DB102 (Enzastaurin) In First-Line Treatment of Glioblastoma (GBM)

Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced FDA’s approval to initiate Denovo’s Phase 2b clinical study of DB102 in patients with newly-diagnosed glioblastoma (GBM) in combination with radiation and temozolomide.

October 15, 2019
·
2 min read
Biotech Bay

BriaCell Announces Closing of Non-Brokered Private Placement of $568,444

BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, announces that it has closed its previously-announced non-brokered private placement (the “Offering”) of common shares in the capital of the Company.

October 15, 2019
·
4 min read
Policy

Titan Medical Announces Filing of Amended and Restated Preliminary Prospectus and Withdrawal of Previously Published Milestones

The A&R Preliminary Prospectus and Registration Statement are subject to completion and amendment.

October 15, 2019
·
10 min read
BioForest

CARD Publishes Lung Cancer Screening Article in Peer Reviewed Journal

The Center for Asbestos Related Disease in Libby, Montana, began screening for lung cancer using low-dose CT scans in 2013.

October 15, 2019
·
2 min read
Lone Star Bio

TXHIA East Texas Hemp Conference to Host Stellar Speaker Lineup, Brenham Texas

After lunch, Dr. Rod Moline and Mr. Joe Williams with the Texas Department of State Health Services (DSHS) will be discussing HB1325 and the role of DSHS with respect to the regulation of consumable hemp product labeling and retailer registration

October 15, 2019
·
2 min read
Deals

Natera Launches Proposed Follow-On Offering - Oct. 15, 2019

Natera, Inc., a global leader in cell-free DNA testing, announced the launch of a proposed follow-on public offering of $175,000,000 of shares of its common stock.

October 15, 2019
·
2 min read
Business

Genomma Lab Internacional, S.A.B. de C.V. Third Quarter 2019 Results Conference Call

Genomma Lab cordially invites you to join its quarterly conference call to discuss results for the third quarter of 2019.

October 15, 2019
·
2 min read